Holocene Advisors’s Outset Medical OM Stock Holding History

Holocene Advisors’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,302	Closed	-$887K	–	950
2022 Q1	$887K	Buy	+1,302	New	+$783K	﹤0.01%	713
2021 Q4	–	Sell	-4,135	Closed	-$3.07M	–	944
2021 Q3	$3.07M	Sell	4,135 -1,003	-20%	-$683K	0.02%	442
2021 Q2	$3.85M	Buy	5,138 +2,795	+119%	+$2.14M	0.02%	417
2021 Q1	$1.91M	Buy	+2,343	New	+$1.81M	0.01%	595

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Holocene Advisors's OM Position: Q2 2022 in Review

Holocene Advisors sold out of Outset Medical (OM) in Q2 2022, closing a stake of 1,302 shares — an estimated $887K sold.

Holocene Advisors first reported a position in OM in Q1 2021 and held it in 4 quarters. The position peaked at $3.85M in Q2 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

Holocene Advisors reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
Holocene Advisors sold 1,302 Outset Medical shares in Q2 2022, an estimated $887K.
Holocene Advisors first reported a position in Outset Medical in Q1 2021 and held it in 4 quarters.
Holocene Advisors's Outset Medical position peaked at $3.85M in Q2 2021.
149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on Holocene Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.